- Home
- CDTX vs TNET Comparison
CDTX vs TNET Comparison
Compare CDTX & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- TNET
- Stock Information
- Founded
- CDTX 2012
- TNET 1988
- Country
- CDTX United States
- TNET United States
- Employees
- CDTX N/A
- TNET N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- TNET Business Services
- Sector
- CDTX Health Care
- TNET Consumer Discretionary
- Exchange
- CDTX Nasdaq
- TNET Nasdaq
- Market Cap
- CDTX 2.8B
- TNET 2.6B
- IPO Year
- CDTX 2015
- TNET 2014
- Fundamental
- Price
- CDTX $219.75
- TNET $54.89
- Analyst Decision
- CDTX Buy
- TNET Hold
- Analyst Count
- CDTX 13
- TNET 4
- Target Price
- CDTX $119.44
- TNET $77.33
- AVG Volume (30 Days)
- CDTX 2.2M
- TNET 512.4K
- Earning Date
- CDTX 11-06-2025
- TNET 10-29-2025
- Dividend Yield
- CDTX N/A
- TNET 2.00%
- EPS Growth
- CDTX N/A
- TNET N/A
- EPS
- CDTX N/A
- TNET 2.65
- Revenue
- CDTX N/A
- TNET $4,971,000,000.00
- Revenue This Year
- CDTX N/A
- TNET $2.49
- Revenue Next Year
- CDTX N/A
- TNET $3.17
- P/E Ratio
- CDTX N/A
- TNET $20.77
- Revenue Growth
- CDTX N/A
- TNET N/A
- 52 Week Low
- CDTX $15.02
- TNET $54.27
- 52 Week High
- CDTX $220.32
- TNET $97.02
- Technical
- Relative Strength Index (RSI)
- CDTX 89.35
- TNET 35.80
- Support Level
- CDTX $102.46
- TNET $54.47
- Resistance Level
- CDTX $218.85
- TNET $56.98
- Average True Range (ATR)
- CDTX 4.30
- TNET 1.78
- MACD
- CDTX 12.80
- TNET 0.04
- Stochastic Oscillator
- CDTX 99.47
- TNET 11.52
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About TNET TriNet Group Inc.
Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.